ArticleScientific reports2023

CRISPR-Cas9 genetic screen leads to the discovery of L-Moses, a KAT2B inhibitor that attenuates Tunicamycin-mediated neuronal cell death.

Sofia Pavlou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.